This study uses UK national survey data to investigate the association between C-reactive protein levels and risk of suicide.
This 38-year longitudinal study of a representative birth cohort (the Dunedin Multidisciplinary Health and Development Study of New Zealand) tests associations between cannabis use over 20 years and a variety of physical health indexes at early midlife.
This cross-sectional survey tested the hypothesis that the association between C-reactive protein and depression is symptom-specific using 3 cross-sectional studies: the NHANES of 2005-2006, 2007-2008, and 2009-2010.
This Viewpoint reports on the accumulating data indicating that inflammation may play a role in a host of psychiatric illnesses.
This Viewpoint discusses the effect of air pollutants on the brain and the benefits of environmental regulations and compliance and enforcement actions.
This proof-of-principle study demonstrated that genomic biomarkers with very good sensitivity and specificity for boys with autism spectrum disorder in general pediatric settings can be identified.
This case-control study finds evidence of inflammation of the anterior cingular cortex in major depressive episodes (MDE).
Goldman-Mellor et al test whether suicide attempts among young people signal increased risk for later poor health and social functioning, above and beyond a preexisting psychiatric disorder.
Ludvigsson and coauthors examine the association between autism spectrum disorders and celiac disease.
Eraly et al evaluate whether plasma concentration of the inflammatory marker C-reactive protein helps to predict posttraumatic stress disorder symptoms.
Khandaker et al test the hypothesis that higher serum levels of interleukin 6 and C-reactive protein in childhood would increase future risks for depression and psychosis.